Testing effectiveness (Phase 2)UnknownNCT02803840What this trial is testingLow-dose Radiotherapy for Diffuse Large B-cell LymphomaWho this might be right forLymphoma Centro di Riferimento Oncologico - Aviano 25
Testing effectiveness (Phase 2)Study completedNCT00040846What this trial is testingAlemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more Fred Hutchinson Cancer Center 60
Very early researchLooking for participantsNCT07548697What this trial is testingA Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin LymphomaWho this might be right forB-cell Non Hodgkin Lymphoma (NHL)DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma (FL) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Testing effectiveness (Phase 2)Study completedNCT03610724What this trial is testingPhase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma PatientsWho this might be right forNon-Hodgkin Lymphoma Novartis Pharmaceuticals 34
Early research (Phase 1)Active Not RecruitingNCT04594642What this trial is testingAZD0486 in Subjects With B-Cell Non-Hodgkin LymphomaWho this might be right forB-cell Non Hodgkin LymphomaDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma+1 more AstraZeneca 226
Not applicableLooking for participantsNCT03280394What this trial is testingLiquid Biopsy in Mature B-cell TumorsWho this might be right forMature B-Cell Neoplasm Oncology Institute of Southern Switzerland 444
Not applicableStudy completedNCT07103486What this trial is testingEvaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Novartis Pharmaceuticals 264
Early research (Phase 1)WithdrawnNCT04052061What this trial is testingQUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B Cell LymphomaLarge-cell LymphomaLymphoma, B-Cell+1 more ImmunityBio, Inc.
Early research (Phase 1)Ended earlyNCT02931110What this trial is testingStudy of IV CBL0137 in Previously Treated Hematological SubjectsWho this might be right forHematological Malignancies Incuron 5
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69
Testing effectiveness (Phase 2)Study completedNCT03097770What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20Who this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more Chinese PLA General Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT03670901What this trial is testingCompare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-Cell Lymphoma JHL Biotech, Inc. 8
Testing effectiveness (Phase 2)Ended earlyNCT03298412What this trial is testingEffect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)Who this might be right forHigh-risk Diffuse Large B-cell Lymphoma Amgen 10
Testing effectiveness (Phase 2)Looking for participantsNCT06517511What this trial is testingSelinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)Who this might be right forDiffuse Large B Cell Lymphoma Sun Yat-sen University 42
Not applicableStudy completedNCT06031194What this trial is testingPharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell LymphomaWho this might be right forCentral Nervous System LymphomaDiffuse Large B-Cell Lymphoma Ohio State University Comprehensive Cancer Center 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT06573645What this trial is testingA Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCLWho this might be right forLymphoma, Large B-Cell, Diffuse Xia Yi 428
Testing effectiveness (Phase 2)Study completedNCT01431209What this trial is testingRuxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell TransplantWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more University of Nebraska 71
Large-scale testing (Phase 3)Active Not RecruitingNCT04628494What this trial is testingTrial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-cell Lymphoma Genmab 483
Testing effectiveness (Phase 2)Looking for participantsNCT06682130What this trial is testingGlofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCLWho this might be right forDiffuse Large B-cell Lymphoma(DLBCL) The First Affiliated Hospital of Soochow University 40
Not applicableStudy completedNCT05349201What this trial is testingCAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)Who this might be right forDiffuse Large B-Cell Lymphoma (DLBCL)Acute Lymphoblastic Leukemia (ALL) Novartis Pharmaceuticals 273